162 results
8-K
EX-4.1
BPTH
Bio-Path Holdings Inc
19 Apr 24
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the- Market Under Nasdaq Rules
9:21am
to the benefits of the provisions of this Section 3(d) regardless of (i) whether the Company has sufficient authorized shares of Common Stock
8-K
EX-4.2
BPTH
Bio-Path Holdings Inc
19 Apr 24
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the- Market Under Nasdaq Rules
9:21am
. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3(d) regardless of (i) whether the Company has
8-K
EX-10.1
BPTH
Bio-Path Holdings Inc
19 Apr 24
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the- Market Under Nasdaq Rules
9:21am
additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is issuing securities primarily … ) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements under any stock option plan
8-K
EX-10.1
BPTH
Bio-Path Holdings Inc
4 Apr 24
Entry into a Material Definitive Agreement
4:35pm
for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option … “Losses”) to which the Company and the Manager may be subject in such proportion as is appropriate to reflect the relative benefits received
8-K
EX-4.1
BPTH
Bio-Path Holdings Inc
26 Mar 24
Entry into a Material Definitive Agreement
8:03am
of doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3(d) regardless of (i) whether the Company has sufficient
8-K
EX-4.2
mpa0sr2z18rbzbtq
26 Mar 24
Entry into a Material Definitive Agreement
8:03am
8-K
EX-10.1
15eu3ihk1e
26 Mar 24
Entry into a Material Definitive Agreement
8:03am
8-K
EX-99.1
bj90ug392q9egjh
8 Mar 24
Bio-path Holdings Reports Full Year 2023 Financial Results
7:10am